Article
Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTI.
Oncology - 1 Jan 2018
Kieler Markus, Müllauer Leonhard, Koperek Oskar, Bianconi Daniela, Unseld Matthias, Raderer Markus, Prager Gerald W
Abstract excerpt
OBJECTIVE: Adrenocortical carcinoma (ACC) is a rare disease with a dismal prognosis. We aimed to evaluate if a personalized medicine approach may be useful for matching patients with ACC to targeted therapies. METHODS: This is an analysis of 10 molecularly profiled ACCs that were progressing under standard of care treatment. The profile consisted of a 50-gene next-generation sequencing panel, immunohistochemistry...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
